Loading...
Thumbnail Image
Item

Discovery of a small-molecule inhibitor that traps Polθ on DNA and synergizes with PARP inhibitors

Fried, William
Tyagi, Mrityunjay
Minakhin, Leonid
Chandramouly, Gurushankar
Tredinnick, Taylor
Ramanjulu, Mercy
Auerbacher, William
Calbert, Marissa
Rusanov, Timur
Hoang, Trung
... show 10 more
Citations
Altmetric:
Genre
Journal article
Date
2024-04-05
Advisor
Committee member
Department
Cancer and Cellular Biology
Research Projects
Organizational Units
Journal Issue
DOI
https://doi.org/10.1038/s41467-024-46593-1
Abstract
The DNA damage response (DDR) protein DNA Polymerase θ (Polθ) is synthetic lethal with homologous recombination (HR) factors and is therefore a promising drug target in BRCA1/2 mutant cancers. We discover an allosteric Polθ inhibitor (Polθi) class with 4–6 nM IC50 that selectively kills HR-deficient cells and acts synergistically with PARP inhibitors (PARPi) in multiple genetic backgrounds. X-ray crystallography and biochemistry reveal that Polθi selectively inhibits Polθ polymerase (Polθ-pol) in the closed conformation on B-form DNA/DNA via an induced fit mechanism. In contrast, Polθi fails to inhibit Polθ-pol catalytic activity on A-form DNA/RNA in which the enzyme binds in the open configuration. Remarkably, Polθi binding to the Polθ-pol:DNA/DNA closed complex traps the polymerase on DNA for more than forty minutes which elucidates the inhibitory mechanism of action. These data reveal a unique small-molecule DNA polymerase:DNA trapping mechanism that induces synthetic lethality in HR-deficient cells and potentiates the activity of PARPi.
Description
Citation
Fried, W., Tyagi, M., Minakhin, L. et al. Discovery of a small-molecule inhibitor that traps Polθ on DNA and synergizes with PARP inhibitors. Nat Commun 15, 2862 (2024). https://doi.org/10.1038/s41467-024-46593-1
Citation to related work
Springer Science and Business Media
Has part
Nature Communications, Vol. 15, Iss. 1
ADA compliance
Embedded videos
License
Attribution CC BY